Single Ventricle Physiology
Conditions
Brief summary
The purpose of this study is to investigates serum and stool biomarkers as predictors for post-operative feeding intolerance in infant patients with complex congenital heart defects who undergo single ventricle staged palliation surgery.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Full term gestational period (37 weeks gestation or greater) * minimum of 2.5kg or greater body weight * diagnosis of single ventricle physiology, or complex congenital cyanotic heart disease requiring staged palliation surgery in the form of Norwood-type procedure, systemic-to-pulmonary artery shunt, or pulmonary artery banding.
Exclusion criteria
* Have diseases affecting other organs, * have major congenital anomalies such as Hirschsprung disease, imperforate anus, CHARGE syndrome, or VACTERL association.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Level of most abundant serum protein as determined by ELISA | baseline (3-5 days after initial cardiac surgery), within three weeks of the initial cardiac surgery | We will select two proteins with top changes that are involved in the pathways for intestinal inflammation, and levels will be determined with either ELISA or other techniques that are available. |
| Level of second most abundant serum protein as determined by ELISA | baseline (3-5 days after initial cardiac surgery), within three weeks of the initial cardiac surgery | — |
| Level of stool biomarker interleukin-8 (IL-8) as determined by ELISA | baseline (3-5 days after initial cardiac surgery), within three weeks of the initial cardiac surgery | — |
| Level of stool biomarker calprotectin as determined by ELISA | baseline (3-5 days after initial cardiac surgery), within three weeks of the initial cardiac surgery | — |
Countries
United States